A new European regulatory framework, Directive 2011/62/EU has been developed in response to the increasing complexity of the current distribution network for medicines, and various incidents involving the counterfeiting of medicines. GDP has also been updated to serve as a reference for distributors when dealing with current challenges and to reinforce the protections of the legal supply chain. These regulatory changes are contributing to the maintenance of the quality and integrity of distributed drugs.
This course will show you how to monitor your supply chain and ensure compliance with regulations.
Why choose GDP for medicines of human use training from SGS?
This course will help you to:
- Meet the principal criteria for compliance during an inspection to obtain certification according to the GDP guidelines of November 5, 2013
- Understand the value, in terms of cost reduction, of compliance with GDP requirements
This course is aimed at directors and those responsible for technical quality, logistics and purchasing in the pharmaceutical sector, as well as internal auditors, consultants and anyone who wishes to know the requirements of GDP in detail.
A leading provider of training for the life sciences
We base our training courses on in depth industry knowledge, extensive practical experience in the life sciences sector and decades of experience as a world leading certification body.
Contact us today to reserve your place in our Good Distribution Practices (GDP) course of medicines for human use.
The pharmaceutical industry is subject to a very high level of regulation, and both manufacturers and users require total confidence in pharmaceutical data.